The Safety, Tolerability and Preliminary Efficacy of Derived Motor Neuron Progenitor Cells (XS228CN) in Subjects With Amyotrophic Lateral Sclerosis
Clinical trial NCT07118319 · RECRUITING
Trial details
- NCT number
- NCT07118319
- Sponsor
- XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-15
- Primary completion
- 2027-01-31
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.